Extension Study to Evaluate the Safety and Immunogenicity of a Revaccination Dose of the RSVPreF3 OA Investigational Vaccine in Adults 60 Years and Older Who Participated in the RSV OA=ADJ-002 Study

Name: Extension Study to Evaluate the Safety and Immunogenicity of a Revaccination Dose of the RSVPreF3 OA Investigational Vaccine in Adults 60 Years and Older Who Participated in the RSV OA=ADJ-002 Study
Published: 2020
License: Public Domain

GlaxoSmithKline · 2020

ClinicalTrials.gov · Datasets · License: Public Domain · 2020

Open Source ↗

immunogenicity respiratory-syncytial-virus safety vaccine

respiratory syncytial virus infections, respiratory syncytial virus, vaccine, safety, immunogenicity, interventional, phase2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Extension Study to Evaluate the Safety and Immunogenicity of a Revaccination Dose of the RSVPreF3 OA Investigational Vaccine in Adults 60 Years and Older Who Participated in the RSV OA=ADJ-002 Study

Related documents